Edwards D J, Spiker D G, Kupfer D J, Foster G, Neil J F, Abrams L
Arch Gen Psychiatry. 1978 Dec;35(12):1443-6. doi: 10.1001/archpsyc.1978.01770360047005.
Platelet monoamine oxidase (MAO) activity was determined with tryptamine as substrate for 61 drug-free patients who had a primary major depressive disorder and for 32 normal controls. Although there were no significant differences between the mean platelet MAO activity of 19 bipolar patients (4.94 nmoles/hr/mg of protein), 42 unipolar patients (4.97 nmoles), and the controls (4.78 nmoles), an analysis of variance indicated that the variance of the bipolar group was significantly greater than that of the other groups. This suggests that there may be subgroups of bipolar patients that differ in their platelet MAO activity but that appear to be distinct from the bipolar I vs bipolar II classification.
以色胺为底物,对61例患有原发性重度抑郁症的未服用药物患者和32例正常对照者测定了血小板单胺氧化酶(MAO)活性。虽然19例双相情感障碍患者(4.94纳摩尔/小时/毫克蛋白质)、42例单相情感障碍患者(4.97纳摩尔)和对照组(4.78纳摩尔)的平均血小板MAO活性之间无显著差异,但方差分析表明双相情感障碍组的方差显著大于其他组。这表明双相情感障碍患者可能存在血小板MAO活性不同的亚组,但这些亚组似乎与双相I型和双相II型分类不同。